Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is a usual trick for both shorts and potential longs to play the card of "they need funding right now or in the very near future."
Yes indeed nwbo needs cash infusion now or in the near future. At this price, I don't think LP will dilute again. There are tons of ways to get "a bridge fund" to go by for a few months, let alone one or two months. I think a bridge fund is in the working now.
One thing I don't like this lady called Linda is her incapability of getting a wall street investment bank onboard in addition to Woody. She is very incompetent in this regard.
And she is greedy, very greedy. She really needs to compromise and think her shareholders.
$1 or $30 or $300? Have a question? Bye, see you all tomorrow.
Dear turtle,
I did buy as I said, 10K around $96 ~ $97 today, and 2k earlier at around $1.02.
Search the internet for biotech stock news and search twitter for biotech stock.
Observation:
Not a general pumping article or commentary from cnbc, Bloomberg, or the like, and all so-called biotech analysts with a name attached all seem to be very happy seeing the whole sector gets take down.
Conclusion:
It is close to the reversal point. It may happen within next couple of weeks.
Anyhow, in the case of nwbo, do I care?
You pair are the laughing stock of the century for this board! Really? if the bragging of your pair is of any cent in content, you pair don't need to toil in this board day and night for minimum wage!
Rich people are not toiling in MB. Mostly only check on their twitter with rest time enjoying life.
I am not rich enough and I am not toiling in mb either, just occasionally posting.
You would not see me posting again in this board, when L or/and D is a success as I have lost track of my share counts.
Keeping buying yesterday and today while having buying order set well below $1.
Again Linda sucks, Les sucks but fortunately their collective sucks already reflected in the price!
BK: nonsense
RS: nonsense
Buy as a drunken sailor: $1 versus $30 or $300!
You still reply to him? Are you a saint?
He is of a fungus in nature. How can you talk to him. You need some fungus killer to get him shut up and have a sense of shame! The same goes to other posters of the same kind who you should be very well aware of at this point.
Hi, RK,
I have this last post for today and I am happy to reply to you:
Yes, I did. Actually, I first heard it when I was in university some thirty years ago, which we had studied it thoroughly.
But in some cases, I am willing to take unproportional risk, nwbo is one of them.
I can give you one other case which I am willing to risk the same just for example:
If crude oil is ever traded in the range of $20 ~ $30 again, I will be willing to put all my money invest in it.
I regretted, part of the reason I have had too much money tied in nwbo at the time, that I did not do so in recent down and up cycle, although I still make some handsome money from it. As I said recently, I sold out most of it, and made that money buy more shares of nwbo.
GL!
Thanks eagle. Yes, I do have faith, though it is not organized but individualized!
BTW, for anyone out there who wants to buy option at this time, it is not wise idea. Instead just buy shares!
God bless you and all longs!
IT HAS ALWAYS BEEN WHETHER YOU LOSS $1.16 (OR 0.XX)OR YOU GAIN $30 OR $100. IT IS OUT OF QUESTION!
I didn't buy a piece yesterday because my wife found out I have bought shares almost every other day with too many already in control. So understandably, she is mad at me.
I took her to a nice dinner with a small band playing loving songs, and she finally agree with me: no way we should stop buying.
So I am free now to use our money to continue this buying spree, but I will exercise caution and make sure we have enough cash for the unthinkable, like the one happened with DNDN.
So I will continuously contribute my part and be determined to see the parting of shares from the control of shorts on a daily basis.
I believe shorts are playing the cards as follow: 1) there would be no imminent good news; 2) the incoming quarterly report would be weak so that the company is in need of money NOW; 3)the general market particularly biotech market may continually weaken.
I also believe LP is fully aware of the situation unless she is as dumb as shorts or should I say as sneaky as shorts.
She is suck, but even a fool will get right from time to time. Now I put her in the rank of fools, which is not contradictory to my investment thesis -- see the first paragraph.
But yes, if we have a better Linda, we would be even more handsomely rewarded.
As usual, good luck and God bless!
My new theory regarding temporary half of screening for new patients, which is not contradictory to my earlier FDA hijacking theory but definitely a lot simpler:
The company, knowing that one major problem which may compromise trial is that the pseudo progression patients are potentially regarded as true progression patients, particularly the mesenchymal subtype of patients (referred to Prins and LL's related papers and videos).
As a result, it voluntarily stopped new patient screening at a time it thought those patients already in the pipeline were enough to get it over to the targeted 348 patient enrolments while submitting information to regulatory agencies (simply referred to FDA below as representative of all three involved agencies). The information submitted contains way to resolve this issue, and asking retrospections of all suspicious cases.
FDA agreed and asked the company to remain at the partial screening halt until further notice after receiving the request and information from the company – now the trial is fully under the control of FDA (an alternative to the hijacking theory).
Dialog has been ongoing back and forth between the company and FDA. On the one hand, FDA may want to make sure the method proposed by the company is indeed trustworthy, scientifically and empirically based (to have a kind of a small trial within the trial to see there is statistically significance so that it can validate the method proposed by the company). This takes lots of time, so six to seven months have passed.
Recently, FDA may have had some data and observed the correlations in which the company has long believed are with merit. It would then ask the company for some further information. As a result, I highly suspect that the company has so far submitted all the relevant information (such as biological assays of all the related or suspected patients before and after the partial halt) to the FDA.
FDA could be in the final validating process now. If it is persuaded, all PFS events will be recounted, which is strongly in the company's favor; if it is not persuaded, anything will be determined as it stands today, or according to the protocol.
I strongly believe and hope FDA will take a scientific, rational and reasonable stance and let the data have the final say.
In the meantime, the 1st and/or 2nd interim analysis events may have been reached, and the analyses may have been conducted with definite analysis data.
Please allow me to conclude with this: It is either $1.xx or $30. You choose, and most importantly, God bless patients to have an effective treatment, and those who believe!
I post this in yh board a few minutes ago:
"As always Smith gets the science part right, but he is too old to catch the essence in investing. Now most people including him are mentally in darkness created by this dragged on lengthy halt for screening for additional patients, even the company has given the light on what will come following the twilight, a big sunny day ahead, when people in the total darkness, they cannot see the overall picture correctly, let alone quantitatively.
The quantity is $1.25 or $30 or even $300 in a few years or maybe sooner. If L is a success, everybody will rash to say that the stock is worthy of at least $30; then since the technology is validated, it will become much easy for its approval in other indications, a mere labeling things; then people will rash to say, $100 a piece is cheap. The same goes for D.
The point is most people are currently in their own darkness induced by the company of course that they cannot see there is a bright future.
On the other hand, no unions are strong, shorts or longs. The current seemingly strong union of short wolf pack will be broken readily and furiously on the various possibilities. When the time comes, these wolves will sell their wives for a change.
There is a word called dynamics, and it is changing at any moment.
Okay, take it or not: $1.25 loss or $30 gain? Is it still a problem, then do yourselves a favor and leave the biotech sector!"
Loss $1.xx Versus Gain $30 is No Question, Ladies and Gentlmen!
BTW, some notable days: 18 May ASCO abstract release day (may or may not see D related, at least we know LP has a huge room for people to hang out there and have a free refreshment); 23 May: new warrant B expiration day at exercise price of $3 (exercised or not, no big problem and I prefer no exercise, none as I are determined to go to the end to see the success of DCVax platform). But be prepared for any unexpected news, good or not good, which is not rare in the stock market.
Again, IMHP it is no difference whether it is $1.34 versus $30 or $1.x or $2.x or $5.x versus $30.
Biotech indexes IBB and XBI are both approaching 52wks low once again as DJIA, S&P and Nasdaq all floats around all time high though there is a selling pressure as summer approaches.
Bitch Harry's comment has been overdone and overspun by Wall Street, the incompetent, and biotech stocks have been oversold. We may just need a trigger for the incompetent hedge fund managers all come to the buy table: some good news from the biotech sector, any news.
In any circumstances, NWBO has been depressed so much, I would think it is one of the few weather proof stocks now.
If not, I don't care because I don't care daily movement a bit.
Just report here: I have always put money where my mouth is. I sold some of my oil stocks of which some have doubled in the last two months and bought additional 5k nwbo around $1.25 (my total is confidential now). Today I am done and I am looking forward to tomorrow.
BTW, I am ready for a major battle with shorts, remembering what had happened with DNDN, I am always ready for substantial quick drop if it would ever happen, but I am ready!
Right, it is now $1.25 versus $30 or is it a big difference if it is $1 versus $30?
IMHO, I don't think so!
Exactly! I have given Jerry, a usual bear a task in yahoo board asking him to dig out how many security exchange non-appliances each major league company would have encountered each year. The poor guy got the number is a lot and all these non-appliances are resolved, but he then quickly said, NWBO is different. LOL
We have talked too many and too much about those trivial issues now as if we were shorts too. Stop it, and try not to reply to obvious party spoilers.
Good luck to you and God bless patients and all longs!
Yes, I saw that too. Let put this way: Linda did and has been asking something, maybe too many things, and FDA has been a bit annoyed as I put in my "Hijack Theory." And the company still is providing further information to regulatory bodies as of 2 May.
As we have said many times there is definitely some thing going on behind scene.
One question, why the company doesn't spell out the number of enrollment it actually has had as of 2 May, instead still letting anyone guessing. This time it said, "well over 300," why not said, about 318 or approximately 308 or 328, etc.
So the number is an issue too?
Even if the L is approved this time, $1.36 a piece is a joke, but I understand it has something to do with the way the company does its business.
But $1.36 or $30? It is a simple question, doesn't it (the last two paragraphs are not a question to you notbrad, and thank you for your input).
[Sorry, Long I was not intended to address your post. Instead it should be a new post]
Linda has been graceful enough and kind enough to short hedge funds, and eventually these bastards are going to return her favor. From today's sec filing:
"3-May-2016
Material Modification to Rights of Security Holders
Item 3.03. Material Modification to Rights of Security Holders.
On May 2, 2016, Northwest Biotherapeutics, Inc. (the "Company") and holders of the Company's Series B Warrants agreed to extend the exercise period of the Series B Warrants an additional twenty-one (21) days from May 2, 2016 to May 23, 2016. Also on May 2, 2016, the Company filed a Prospectus Supplement Amendment for the sole purpose of disclosing this extension of the exercise period of the Series B Warrants. The Prospectus Supplement Amendment does not provide for any new sale of securities of the Company.
The Series B Warrants were originally purchased by certain institutional investors (the "Purchasers") as part of a registered direct offering (the "Offering") that closed on March 3, 2016, and are described in the Prospectus Supplement and Current Report on Form 8-K, both filed by the Company on March 3, 2016. The currently outstanding Series B Warrants are exercisable for the purchase of 5,882,353 shares of the Company's common stock, par value $0.001 per share (the "Common Stock") at an exercise price of $3.00 per share."
Although I am determined to see these bastards get burned as badly as possible, Linda is the one in the rein.
She has saved the shorts! If shorts have nothing to return her favor, she will be the dumbest CEO I have ever known.
It is a process, and any process takes time!
[this indeed is my last post for today.]
RK, you should play S&P stocks, not tiny biotech company's stock if you are really an independent investor.
The higher the risk, the higher the return! $1.5 risk of loss, and $30 potential gain in a few months? LOL
Nobody can tell what the price will be in the near term, that's why most daytraders, the ones who have endured the most stress in market, fail.
If you believe you will be rewarded multiple baggar, whether the bottom is $1.5, or $1 is not important. Otherwise really, you should look at S$P stocks.
I said the above in all my honesty. I would add this may be my last post for today, and good luck.
Even that, it is normally a lengthy and complex process. In normal situation, minority like us retail investors may not have a say as long as the majority decided to do something, but in the case of a publicly traded company intended to take it private, our minority rights must be satisfied for the company to be able to do so in most states where companies register.
In case, there is dispute, the courts will have the final say, for instance, how much each share is worth, or how we minority shares holders shall be paid and how much.
Privatization in the case of NWBO is zero probability. Let it rest: If the company fails, it is nonsense; and if the company succeeds, it will be the best interests for both Linda and other investors to keep it public.
THIS INVESTMENT IS GETTING EASIER FOR ALL OF US FOLKS:
IT IS STILL $1.38 OR $1.58 LOSS OR $38 GAIN OR $188 GAIN!
NO LOOKING AT DAY TO DAY UPS AND DOWNS, FOLKS, FOCUS ON THE HORIZON.
TODAY'S EVENT IS JUST A HARBINGER ON WHAT WILL COME: SUCCESSES OF TRIALS & NORMALIZATION OF THE COMPANY.
GOOD NIGHT!
That's a good question. One thing for certain is that LP now has to be operating under the sun, which is a big plus. Those many millions of shares issued to Cognate have to be reduced in value either by hiking the price per piece or cutting the total numbers, which is good for retail investors either way!
One other way forward is to use the balance of the aggregate issuance in question as future payment!
I am glad to hearing today's news, particularly this only negative part of all good news, because it signals changes are coming in the positive way.
The update on P2 D trials with three different sets of leading parties in three different cancer indications are all good. My hope is NWBO will still get a fair good of deals with other parties under the current difficult situations.
As far as L-trial is concerned, it certainly is assuring, and the issue will be resolved soon. After that, I bet the final data will come quickly with FDA decision.
Thanks Diver,
Enjoying reading your post since you were on board. I have told myself some time ago to not post any more because it is really useless at this point and there has been nothing new we have not be aware of, except buying some more shares here and there, kind of just like an "impulsion." But seeing so many fellow longs who obviously have bailed out recently have made me sad. Thinking my personal investment experience and my opinion specifically re nwbo might be of any value, so the post I wrote.
I have seen this happened repeatedly that people would continually bait out even the price were down to pennies, though what they had sold out would turn out to be actually perhaps the most profitable bet they have ever made in life.
A national newspaper (ST) reprints the risk factor statements of a tiny company's 10K, which are actually there in every 10K of the previous years, as if they are new stuff and it has found a new continent in a slanderous way is laughable and as clear as day of its motivation.
It says something about the worth of the company at $1.39 a piece.
This is my last post and God bless you.
"Nobody can reach her to engage and seek confidence in the business."
Have you tried or heard anyone who has tried but could not reach her? Has she refused to talk to Neil Woodford too?
An utterly slanderous article in ST when investigation is still ongoing which is well within the promised period of at least 90 days says loud and clear of the paper's intention.
I have urged the company to conserve cash and temporarily abandon all other activities except for L.
Patience is only thing we can exercise now plus some dry power. Give her some more time and we will see what will happen.
Thank you Senti for your encouragement and all the inspirational posts you have posted.
My assessment of the current situation is cruel, funny, dumb but understandable as I continually see people bail out at this low price and see no fundamental changes of the company (go back to read all those sec filings).
Nothing changes except price ebbing; nothing changes except pessimism which takes control; nothing changes except people bail out.
Nothing changes except the current macro environment is still unfavorable to biotech companies in general; nothing changes except shorts have some more days enjoying paper profit.
Neil Woodford probably signed an NDA while "our existing investors," the usual shorts were most likely aware of no materials, the public not known information when they signed the recent financing deal.
Definitely, we will come out with some kind of approval if it is not comprehensive in scale, at least it will be to the scale that CLDX would have claimed success (as a matter of fact, it failed) in terms of treatable patient population.
NWBO was probably and has been "hijacked" by FDA for the good of everybody at the end though continually "blinding" or depleting the company and the general public of any update or news until there is a decision. Linda is too demanding, sciences advance too fast, FDA is annoyed, FDA takes full control of the course, at end, data will have a definite say. The fat lady will sing!
What on earth can you expect LP to tell you as the only responsibility of hers regarding the L trial seems only to make sure the staff involved in the trial to get paid, the information or new information asked by FDA to get filed and submitted.
If you have guts, buy as a drunken sailor; if not, stay away from computers or bail the fk out!
Com'on, people IT IS $1.39 VERSUS $30, $60, OR EVEN $100!
You need a steel will or go take a vacation, or relief yourselves by selling.
I have been in similar situations too many times, jazz when it was trading at $1, DNDN when it was trading at around $5, VNDA, when it was trading around $1, ARNA when it was trading around $1, HZNP when it was trading at $1.5, PATH when it was trading around $1... when almost nobody said any thing good about these companies, when the rumors ran high about imminent bankruptcy! Similar things happens now as I saw people bail out instead they should just buy, buy and buy...
Com'on, people, I really hate to see the pessimism once again take over when what we actually see is the end, the very happy ending is just in horizon!
Com'on, $1.38 loss or $30 dollar gain, you choose.
At such a test time, I have only those people to thank for: patients for participating in the trial, and the shorts for making it possible for my growing share counts!
While I am positive about the outcome, I also have a contingency plan: If L fails, I expect share price could temporarily be halved, I will buy half the numbers of my current holding at that price, and waiting for a while to unload half of my total holding and wait out with the rest half for L to be used in HE program, and D to be tested and successful in one or two indications!
Please, go back to reading those SEC files or just reading my posts in this board, please. You will find truth!
BTW, Linda is not a crook though a difficult lady to deal with!
No reply doesn't mean I agree with your opinion! So don't expect I will bite!
$1.5 loss or $30 gain is out of question
For new investors
It is out of question
For existing investors,
Sell, sell, sell
As new blood is better than the old!
Game always starts and ends at Level II. Unless Cognate and LP are selling, no way the shorts can have that kind of luck to cover their butts without seeing significant share appreciation.
Abundant shares at Level II? Anytime, when shares at ask got taking out, those abundant shares moved away as if they feared they would be taken out too, all done by machine automatically of course. There are no abundant shares to sell!
Only possibility is some institutional selling, which I doubt it either. Except woody, institutional holding is almost nothing.
You got to kidding yourself by saying, "They could have accumulated 6M shares over the last 60 days without moving the price above 2.00." If they wanted to accumulate, at best one million shares are maximal as some retail longs and flip floppers have sold. That's it. The market makers, i.e., now mostly the shorts have just changed hands with some shares back and forth to each other or from one account to another while taking some getting loose shares from a few retail investors and a few tiny trading firms who lose faith.
Now, they have even bored themselves off this game as we continually see thin and thinner trading volumes without any news, good or bad, meaning they will no longer have the luck to get loose any shares from the retail investors, thus continually doing so is both useless and meaningless.
Let us hope LP can find means to get through this difficult period and let those dilutive future shares and warrants expire.
One way she can do is cutting all unnecessary services and operations, and if the company has to get a financing deal, please leave "the existing investors" alone, and try to get someone who is a true believer, like Woodford.
Shorts have no vision so I doubt they will proceed to bite.
There are too many theories, but often it may be just plain and simple like this:
Aware of trial abnormalities that accrued PFS events are higher than expected while OS events are much lower than expected, the regulatory agency such as FDA determined to have a look at data to see what really was happening. The company was ordered (or recommended) to temporarily halt screening for new patients while regulatory agency or agencies were investigating and analyzing data. Both the company and the agencies initially thought it would be truly temporary in nature as the enrollments were already approaching the target 348 patients, and it would be unwise not to finish the enrollments.
However, the preliminary analysis showed that it seems every patient is living longer but the difference between patients in placebo arm and treatment arm is not clear enough due to lacking of events from both arms. In the meantime, the PFS difference between the two arms is either merely statistically significant at targeted number (four months) or messed up due to pseudoprogessing patients.
The agency or agencies then determined to see more OS events in order to have a clear picture of what is really happening while let the company and the general public "blinded," who can only guess, speculate, etc.
The saga may go much longer or end at any time. If the agencies' check points for analysis are predetermined OS events, such as those at interim and final look, the company may have a better idea than all of us as to when the agencies may have a decision since it knows roughly when certain events are going to be reached.
Because even if PFS difference is statistically significant (or not) and the patients overall are living longer, for instance, more than 28 months or 30 months or above in overall, because it has not been definite yet that the OS difference between the two arms is large enough and statistically significant due solely to insufficient OS events with which the agencies can make a decision, the trial has to continue as it is.
In such circumstances, it would seem unwarranted to lift the temporary screening halt while it would be uncertain on whether to cross placebo patients to receive treatment before their progressions either.
This may be what has been happening, and we cannot do anything but wait.
But at the current bankruptcy price, it is truly easy for new buyers to have a position. Yes, the company needs money to keep going. At this time what kind of financing deal it will have is just anyone's guess. As far as RS is concerned, it is pure nonsense and premature. As one poster said it would be suicidal to do so at the near future, and it is absolutely unnecessary. So how about delisting? This speculation is even funnier than RS. Most investors should have known even if the price is below $1 for a month or two consistently so that the company might receive a delisting warning , the company still has 180 days to work it out. At that time, we will probably know the fate of L and/or D trials.
At the time being, it is still $1.5 total loss versus $30 gain investment thesis if you ignore daily price fluctuation.
Besides we should not forget recent progresses on biomarker and identification of subtypes of patients who will have the most benefits from DCVax. Nobody knows whether these new advancements are part of the current saga, and if the answer is yes it will certainly make the investment even better.
$1.5 loss or $30 gain?
Good night.
Then, no companies are investable if one reads the warning section literally, particularly those small biotech companies; no patients should take any medicines if they read those warnign labels literally; no human beings should leave their houses to work, have fun, and do usual rounds if they are awared of they could be killed in a car accident, by a falling meteorite from sky ... And it is not safe at home either! Then, what to do?
Investing in a small biotech is a high risk and high return game!
BTW, If the company receives a definite notice from FDA, just as you have suggested, do you think the company must report it in an unambiguous way? Yes, LP is a crook, isn't she?
FYI, This is my last post for today!
I asked you to give us an executive summary. I think I should give you mine.
Executive Summary:
There have been no fundamental changes of the company. Otherwise, the company must have reported it. As a result, I am a buyer. actually since the price droped to $7, I have always been a buyer.
As for who is misleading or more misleading, I don't know. Let others to judge if that is important.
At least, I put my money where my mouth is! How about you?
Here you go to have my last post for today:
Internal investigations are rarely published in most cases just from my limited experiences in dealing with publicly traded companies.
What usually happen though is that the underlining company will modify, improve and enhance its internal control and correct some wrong doing (or inappropriate practicing) internally, which the public may be clued by some changes revealed here or there, such as SEC filing.
But in the case of NWBO, it is kind of special and highly polarized case, so I don't think the board will keep quiet after the investigation is completed, and it is in the best interest for the company to say something about the results of the investigation.
So I do expect something which will come out of this ongoing investigation. But personally, I don't have high expectation about that.
If I have a wish, it will be for L to be approved for the good of patients and those true longs who have invested their hard earned money, times, emotions into this noble cause while serving a true blow to those who don't want to see this company to be successful, including those shorts, flip flopers who cannot keep their stinky months shut.
One way to do that is no news until the real news is ready.
Great, Many thanks to you TC Trader
Good luck!
that is related to Kite, not nwbo. Besides, if anything similar happens to nwbo, no way LP would have kept quiet for so long a time.
It probably has something to do with amendments to the existing protocol to also allow for the approval of certain subtypes of patients under the existing trial setting, and to confirm new findings, like the one just published by Dr. Prins, and LL.
BTW, the publication is very recent, but the company knew the results much much earlier, at least six months earlier.
BTW2, at this bankrupt price, have you guys been buying, but yes I do.
Starting from today, I am intending to lump in some 50k more shares for just having some fun, meaning trading in and out because waiting is so boring!
Today, I bought some at $1.57, the price instantly dropped to $1.55, then I bought some more at $1.56, and then the price almost instantly dropped to $1.55, $1.54. It going on like that, very funny.
My high salute to this hardworking market maker. BTW3, can anyone locate this particular market maker?
Please let all your negative opinions for yourselves until the price hits $5 except all usual bears and AF or those who have nothing to do but vent in this tiny board!
BTW, has AF bought shares too recently?
I agreed with you on his intention, but he made an unforgiving mistake for his underestimation of LP, and overestimation of his power.
Besides, his timing was suck. He never saw such a low price be coming. This guy although successful, in small biotech investment he is just a novice!
Hope he has learned a valuable lesson!
Chinatown or Not Yet bluesky,
What else have we not yet talked about? Nothing. My silence recently has reflected my feeling that nothing new has been talked in this board except for Dr. Robert Prins and Linda Liau's recent publication of biomarker, which is quite exciting, coupled with the we-all-known long survival of M-subtype of patients.
Lots of things are going on behind the scene, some have been going on for months now and some may just begin, and things may be tangled together...
Under the grand but nerve-wearing silence (partial halt), something new has to be happening, 1st interim events, second interim events, combination trials, ...
Will FDA finally feel enough is enough, or will the company finally feel enough is enough? Will the science finally come out of cloud smiling?
It's enough for me, share counts or my patience, but I have no choice but wait, even one more year I still have to wait!
Still want to have the dry powder ready for any unexpected turn as long as my DD has not changed, which is LP sucks, LG sucks, but science works thanks to LL and Prins, etc, and Cognate, yes Cognate too, and those who actually run and participate or participated the trials!
Under the public eye, LP will correct her mistakes or obsolete terms set in the long past. She is evolving in the right direction.
Anyhow, at $1.6 per share, no negative words are warranted in terms of investment, or fishing, or gambling on nwbo, regardless what you call it.
I have said that before, if it were not due to my dislike of LP, and LG, my share counts would have been double what I have held today, which is already a huge pile of numbers. Nothing is perfect, you got put things in perspective!
There are at least two patients who stated their treatment schedules in social media/patient forums, which definitely fall within the screening half period, meaning their first treatment began after the halt, and they continually receiving scheduled treatments.
I don't have the habit to keep copies or screenshots or links handy, but you can ask AVII or Koman who knew it and may have links for you.
BTW, if anyone is still buy shares as I do, buy small batches separately to nail a few cents cheaper in overall. Every time I bought, quickly the price would drop to around where I bought. It goes like this for a few weeks now as far as I remember, signifying a tight control by MMs (all shorts related obviously, but to my advantage as well if I buy as we all are waiting the inevitable: good or bad news coming in horizon!)
As far as safety is concerned, please let that recess. It is absolutely no reason for the current partial halt to have anything to do with that. Any safety related issues ought to be notified to the public ASAP. Besides the trial is for advanced cancer patients not for preventative vaccine for kids. A few SAEs, even they are related to the underlining trials are quick normal, but I don't think there are any established relation yet between SAEs and DCVax-L.
Did you think he has any credit by staying how he and les and LP have been his friends while posting his discussions with Les in Yahoo board? What kind of a person is that?
He flip flops more often than you do Ready in his investment in NWBO.
And like you when he does that, his mood and investment thesis in NWBO also flip flops.
Flip flops are nothing wrong, and I do that in other stocks I think are appropriate, but I never ever flip flop my mind along with it because I am fearing of karma, feel uneasiness of a shady persona, and of course I don't believe it will change the share price.
But definitely he or the like thinks his posts can change the market so that it will help his investment.
But flip flop of a mind, give me a break!
You sure you replies to my right post, which was quickly deleted by whoever behind the scene who is quick and very diligent recently in deleting posts.
You need to understand how DMC and sponsor work regarding clinical trials. I can tell you for certainty the current temporary halt has nothing to do with futility just as I have told Pryy one thousand and one time it has nothing to do with safety either, for which he has quiet moved on to attack other trial thing, which of course has been magnified thousand times.
Since you "seems to be concerned with my loss" I am telling you this: No I have no significant loss even in my option since I have not sold any, and I have no intention to sell any. Instead I have kept my promise based on my DD to continually buy as long as the price is in this level and below. My last buy happened in last Wednesday:
1) The fundamentals have not changed;
2) The share price has already factored in that L being a failure, which is not and instead it can be a huge success, and can be a new standard of care;
3) I am 100% sure even L is a failure in P3 trial, some subgroups which are more than IMUC and CLDX had targeted combined in population will see significant benefits so that HE program will start and the company will start taking income, so will UK, etc;
4) D has and always has decent shot in success in at least more than one indication;
5) If either L or D is proven a success in one indication, all the current models or evaluation on the price all have to be multiplied since it will be easy to make the next indication a success, of which some indications are just a labeling issue.
Again taking this opportunity and in case a company official is reading, I have always asked the company not to rash to start D, not at this time. Please conserve cash and focus on L.
All in all, I am a buyer.
Hi Beartrap,
Do you plan to attend the upcoming World Vaccine Congress 2016 in DC? If yes, please update us on anything you come by!
Thanks,
Dan
Regards DNDN, manufacturing was indeed a problem, so was insurance coverage, ill-planning and implementation, etc., though not the critical one, as many have pointed out.
Its sale of provenge was and has been terrible, chiefly because its meager benefits and high costs on the backdrop of cheap, more affordable and easy to manage competing therapy, which was just approved around the same time as DNDN.
Simply there are too many reasons, and I am happy to see LP has learnt some lessons which might affect us, but in any circumstance, DCvax and Provenge are a huge gorge difference in many ways.
You are talking about legal shorting, which I am fine with it, but we are talking about the illegal shorting, which could be in various forms, naked shorting is just one.
This is my last post for today. Good luck!